Drug Shortage Report for MYLAN-BUDESONIDE AQ

Last updated on 2020-01-21 History
Report ID 23166
Drug Identification Number 02230648
Brand name MYLAN-BUDESONIDE AQ
Common or Proper name BUDESONIDE AQ
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 100MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL
Packaging size 165
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-04-16
Actual start date 2018-04-16
Estimated end date 2020-01-30
Actual end date 2020-01-20
Shortage status Resolved
Updated date 2020-01-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v132 2020-01-21 French Compare
v131 2020-01-21 English Compare
v130 2020-01-13 French Compare
v129 2020-01-13 English Compare
v128 2019-10-01 French Compare
v127 2019-10-01 English Compare
v126 2019-09-03 French Compare
v125 2019-09-03 English Compare
v124 2019-08-23 French Compare
v123 2019-08-23 English Compare
v122 2019-08-07 French Compare
v121 2019-08-07 English Compare
v120 2019-07-23 French Compare
v119 2019-07-23 English Compare
v118 2019-07-16 French Compare
v117 2019-07-16 English Compare
v116 2019-07-03 French Compare
v115 2019-07-03 English Compare
v114 2019-06-18 French Compare
v113 2019-06-18 English Compare

Showing 1 to 20 of 132